This site uses cookies to bring you the best experience. Find out more
Skip to main content

News

Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also follow us on LinkedIn  


OrganOx receives FDA approval for metra device

OrganOx receives FDA approval for metra device OrganOx, a world leader in normothermic machine perfusion (NMP), today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its metra system. The OrganOx metra is a fully automated NMP device for the preservation and transport of donor livers destined for transplantation. The marketing approval includes both livers... Read more

The Oxford Science Park Innovation Award returns as Oxfordshire Business Awards resume

The Oxford Science Park Innovation Award returns as Oxfordshire Business Awards resume Apply now to join previous winners – Oxford Space Systems, Perspectum Diagnostics, Adaptix & Oxford Biomedica Oxford, UK, December 3 2021 – Oxfordshire companies which are progressing valuable innovations can apply now for The Oxford Science Park Innovation Award, one of 2022’s Oxfordshire Business Awards (OXBA). The Oxford Science Park, one of the UK’s... Read more

The Oxford Science Park and Occupiers Gather to Celebrate Success

The Oxford Science Park and its occupiers gathered together recently to celebrate successes and progress over recent months – a period in which the importance of science and technology companies in keeping the population healthy became clearer than ever. Companies from across the Park, including LRE System, Oxford Endovascular, Oxford Vacmedix, OXGENE, Oxsonics Therapeutics, Physiomics, ProImmune and Sitryx, chatted to attendees from Advanced... Read more

Sitryx appoints Tanya E. Borsuk, Ph.D., as Chief Business Officer

Oxford, UK – 10 November 2021 – Sitryx (“the Company”), a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying therapeutics in immuno-inflammation and immuno-oncology, today announces the appointment of Tanya E. Borsuk, Ph.D., as its Chief Business Officer. Tanya brings 15 years of strategic and scientific expertise across business development and corporate strategy. At Sitryx, Tanya will join the... Read more

OMass Unveils Rich Drug Discovery Pipeline

OMass Unveils Rich Drug Discovery Pipeline Targeting Intractable or Inadequately Drugged Membrane and Complex-bound Proteins Oxford, United Kingdom – 4 November 2021 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying medicines against highly validated target ecosystems, today unveiled its pipeline of five novel, differentiated small molecule drug programs, targeting intractable or inadequately drugged... Read more

The Daubeny Project

Imaginative design, inspiring spaces.